Job Watch

EMBL: Phenomics Team Leader

New Scientist - Bioinformatics - Mon, 2019-05-06 05:35
Competitive Salary: EMBL: Phenomics Team Leader Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

Lucidity in Dementia (R21/R33 Clinical Trial Optional)

Funding Opportunity RFA-AG-20-017 from the NIH Guide for Grants and Contracts. This FOA is intended to advance scientific understanding of lucidity in dementia by supporting an initial set of retrospective and/or prospective studies that will lay the groundwork for further research on this topic. Studies supported by this FOA will use the R21/R33 phased innovation mechanism to support initial exploratory/developmental aims during the R21 phase followed by further expanded aims during the R33 phase.

Lucidity in Dementia (R21 Clinical Trial Optional)

Funding Opportunity RFA-AG-20-016 from the NIH Guide for Grants and Contracts. This FOA is intended to advance scientific understanding of lucidity in dementia by supporting an initial set of retrospective and/or prospective studies that will lay the groundwork for further research on this topic. Studies supported by this FOA will use the R21 mechanism to support initial exploratory/developmental aims that will serve as the foundation for future studies.

Illumina: Bioinformatics C++ Developer

New Scientist - Bioinformatics - Fri, 2019-05-03 11:39
Competitive salary + Pension, health insurance, gym membership, bonus and many more benefits: Illumina: Be part of highly motivated bioinformatics team working on developing fast and accurate analysis workflows for both rare genetic diseases and oncology Great Abington, Cambridge
Categories: Job Watch

HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)

Funding Opportunity PAR-19-267 from the NIH Guide for Grants and Contracts. Funding Opportunity PurposeThe purpose of this NIH Mentored Research Scientist Development Award (K01) is to provide salary and research support to investigators who are within ten years of completing their terminal professional degree or residency training. Research and mentorship must be in the field of HIV/AIDS translational studies, using nonhuman primates (NHPs) as pre-clinical models. These awards will provide 3 years of support for intensive research career development under the guidance of an experienced mentorship team, with expertise in both the pre-clinical application of NHP HIV/AIDS models and in translation of the results from such studies to clinical application in humans. The expectation is that through this sustained period of research career development and training, awardees will launch independent research careers and become competitive for new research project grant (e.g., R01) funding. This funding initiative addresses all objectives of the fiscal year (FY) 2019/2020 NIH strategic plan for HIV and HIV-Related Research (https://www.oar.nih.gov/hiv-policy-and-research/strategic-plan), including research directed towards prevention and cure of HIV infection; next-generation therapies; understanding the roles of comorbidities, coinfections and complications; and cross-cutting activities such as research training and building capacity.

Conference for Early Stage HIV/AIDS Researchers Using Nonhuman Primate Models (R13 Clinical Trial Not Allowed)

Funding Opportunity PAR-19-268 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages Research Conference Grant (R13) applications to conduct an annual intensive workshop/conference/meeting that addresses the needs of early stage HIV/AIDS researchers utilizing nonhuman primates (NHPs) as they translate preclinical research from NHPs to human clinical trials. The objectives of the meeting(s) supported by this FOA are to provide these early stage HIV/AIDS researchers with guidance on conducting preclinical research to inform clinical trials on reducing the incidence of HIV/AIDS infection, including vaccine development and testing; developing next-generation HIV therapies, including potential cure therapies; treatment of HIV-associated coinfections, comorbidities and complications; and infection prevention strategies. In addition to guidance on translating results to clinical trials, the conference should target developing skills related to networking, grantsmanship, and goal/milestone-driven projects. Conference topics should also include other considerations such as statistical and host genetics considerations; methods to translate the results of NHP studies to clinical trials in humans; and how to develop new NHP research programs to better reflect clinical observations and findings in human HIV/AIDS patients.

Wellcome Sanger Institute: Postdoctoral Fellow - Computational

New Scientist - Bioinformatics - Thu, 2019-05-02 14:26
Wellcome Sanger Institute: Job Reference 83461 Postdoctoral Fellow - Computational Salary range £31,897 - £39,240 (dependent on experience) plus excellent benefits Fixed Hinxton, Cambridgeshire, England
Categories: Job Watch

HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-19-041 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from investigators to participate in the HLA and KIR Region Genomics in Immune Mediated Diseases Consortium (HLARGC). This cooperative research group supports projects defining the association between variations in the human leukocyte antigen (HLA), also known as the Major Histocompatibility Complex (MHC), and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including outcomes following cell, tissue, and organ transplantation.

HLA and KIR Region Genomics in Immune-Mediated Diseases (U19 Clinical Trial Not Allowed)

Funding Opportunity RFA-AI-19-044 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications from investigators to participate in the HLA and KIR Region Genomics in Immune Mediated Diseases Consortium (HLARGC). This cooperative research group supports projects defining the association between variations in the human leukocyte antigen (HLA), also known as the Major Histocompatibility Complex (MHC), and natural killer cell immunoglobulin-like receptor (KIR) genetic regions and immune-mediated diseases, including outcomes following cell, tissue, and organ transplantation.

EMBL: Senior Software Developer - European Genome-phenome Archive

New Scientist - Bioinformatics - Thu, 2019-05-02 05:37
Competitive Salary: EMBL: Senior Software Developer - European Genome-phenome Archive Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Development-Operations Engineer - European Genome-phenome Archive

New Scientist - Bioinformatics - Thu, 2019-05-02 05:37
Competitive Salary: EMBL: Development-Operations Engineer - European Genome-phenome Archive Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Ensembl Compara Project Leader

New Scientist - Bioinformatics - Thu, 2019-05-02 05:36
Competitive Salary: EMBL: Ensembl Compara Project Leader Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

EMBL: Bioinformatics Developer

New Scientist - Bioinformatics - Thu, 2019-05-02 05:35
Competitive Salary: EMBL: Bioinformatics Developer Location: Cambridge, Cambridgeshire, England
Categories: Job Watch

Pages

Subscribe to Anil Jegga aggregator - Job Watch